Literature DB >> 27476174

Assessing in vivo platelet activation in patients with liver diseases.

Ton Lisman1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 27476174     DOI: 10.1007/s11239-016-1405-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  16 in total

1.  Pitfalls in assessing platelet activation status in patients with liver disease.

Authors:  Ton Lisman; Robert J Porte
Journal:  Liver Int       Date:  2011-12-30       Impact factor: 5.828

2.  No evidence for an intrinsic platelet defect in patients with liver cirrhosis--studies under flow conditions.

Authors:  T Lisman; J Adelmeijer; P G de Groot; H L A Janssen; F W G Leebeek
Journal:  J Thromb Haemost       Date:  2006-07-12       Impact factor: 5.824

3.  Increased thromboxane metabolites excretion in liver cirrhosis.

Authors:  G Davì; D Ferro; S Basili; L Iuliano; C Camastra; C Giammarresi; S Santarone; B Rocca; R Landolfi; G Ciabattoni; C Cordova; F Violi
Journal:  Thromb Haemost       Date:  1998-04       Impact factor: 5.249

4.  No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.

Authors:  Edris M Alkozai; Robert J Porte; Jelle Adelmeijer; Alberto Zanetto; Paolo Simioni; Marco Senzolo; Ton Lisman
Journal:  Thromb Res       Date:  2014-11-23       Impact factor: 3.944

5.  Preserved hemostatic status in patients with non-alcoholic fatty liver disease.

Authors:  Wilma Potze; Mohammad S Siddiqui; Sherry L Boyett; Jelle Adelmeijer; Kalyani Daita; Arun J Sanyal; Ton Lisman
Journal:  J Hepatol       Date:  2016-06-11       Impact factor: 25.083

Review 6.  Hemostasis in liver disease: implications of new concepts for perioperative management.

Authors:  Pepijn D Weeder; Robert J Porte; Ton Lisman
Journal:  Transfus Med Rev       Date:  2014-03-15

Review 7.  Coagulation in liver disease: a guide for the clinician.

Authors:  Patrick G Northup; Stephen H Caldwell
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-16       Impact factor: 11.382

8.  An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.

Authors:  Greg C G Hugenholtz; Jelle Adelmeijer; Joost C M Meijers; Robert J Porte; R Todd Stravitz; Ton Lisman
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

9.  Hemostasis activation in patients with liver cirrhosis.

Authors:  T Vukovich; H Teufelsbauer; M Fritzer; S Kreuzer; P Knoflach
Journal:  Thromb Res       Date:  1995-02-01       Impact factor: 3.944

Review 10.  Hypercoagulation and thrombophilia in liver disease.

Authors:  P G Northup; V Sundaram; M B Fallon; K R Reddy; R A Balogun; A J Sanyal; Q M Anstee; M R Hoffman; Y Ikura; S H Caldwell
Journal:  J Thromb Haemost       Date:  2007-09-24       Impact factor: 5.824

View more
  1 in total

Review 1.  Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?

Authors:  Marie-Astrid van Dievoet; Stéphane Eeckhoudt; Xavier Stephenne
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.